Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cannabinoids as pharmacotherapies for neuropathic pain: From the bench to the bedside
Authors
Keywords
-
Journal
Neurotherapeutics
Volume 6, Issue 4, Pages 713-737
Publisher
Springer Nature
Online
2009-09-28
DOI
10.1016/j.nurt.2009.08.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Spinal Microglial and Perivascular Cell Cannabinoid Receptor Type 2 Activation Reduces Behavioral Hypersensitivity without Tolerance after Peripheral Nerve Injury
- (2009) Alfonso Romero-Sandoval et al. ANESTHESIOLOGY
- The Endocannabinoid System: A Promising Target for the Management of Type 2 Diabetes
- (2009) Andre Scheen CURRENT PROTEIN & PEPTIDE SCIENCE
- Unknown
- (2009) Aldric Hama et al. JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT
- Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain
- (2009) Anna Leichsenring et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1−/− and not CB2−/− mice in models of acute and persistent pain
- (2009) Nova M.H. Sain et al. NEUROPHARMACOLOGY
- Δ9-Tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew
- (2008) Andrew P. Ray et al. BEHAVIOURAL BRAIN RESEARCH
- Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands
- (2008) Karin Worm et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model
- (2008) J Desroches et al. BRITISH JOURNAL OF PHARMACOLOGY
- MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
- (2008) M Naguib et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adverse effects of medical cannabinoids: a systematic review
- (2008) T. Wang et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Evidence for a novel functional role of cannabinoid CB2receptors in the thalamus of neuropathic rats
- (2008) M. D. Jhaveri et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Study of the regulation of the endocannabinoid system in a virus model of multiple sclerosis reveals a therapeutic effect of palmitoylethanolamide
- (2008) Frida Loría et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain
- (2008) Wataru Yamamoto et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Decreased basal endogenous opioid levels in diabetic rodents: Effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception
- (2008) Jovan Williams et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways
- (2008) Taku Watanabe et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Design and Synthesis of a Novel Series ofN-Alkyl Isatin Acylhydrazone Derivatives that Act as Selective Cannabinoid Receptor 2 Agonists for the Treatment of Neuropathic Pain
- (2008) Philippe Diaz et al. JOURNAL OF MEDICINAL CHEMISTRY
- Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain
- (2008) I. Racz et al. JOURNAL OF NEUROSCIENCE
- Interferon- Is a Critical Modulator of CB2 Cannabinoid Receptor Signaling during Neuropathic Pain
- (2008) I. Racz et al. JOURNAL OF NEUROSCIENCE
- A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
- (2008) Barth Wilsey et al. JOURNAL OF PAIN
- Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats
- (2008) E. J. Rahn et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
- (2008) B. B. Yao et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
- (2008) Ronald J Ellis et al. NEUROPSYCHOPHARMACOLOGY
- A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors
- (2008) S. McGaraughty et al. NEUROSCIENCE
- A prospective identification of neuropathic pain in specific chronic polyneuropathy syndromes and response to pharmacological therapy☆
- (2008) Cory Toth et al. PAIN
- Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons
- (2008) Uma Anand et al. PAIN
- The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain
- (2008) Penny C. Staton et al. PAIN
- Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE)
- (2008) Camille J. Olechowski et al. PAIN
- Effect of Cannabinoid Receptor Agonists on Streptozotocin-Induced Hyperalgesia in Diabetic Neuropathy
- (2008) Magdalena Bujalska PHARMACOLOGY
- Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved
- (2008) Francesca Comelli et al. PHYTOTHERAPY RESEARCH
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
- (2007) J Guindon et al. BRITISH JOURNAL OF PHARMACOLOGY
- In vitroandin vivocharacterization of A-796260: a selective cannabinoid CB2receptor agonist exhibiting analgesic activity in rodent pain models
- (2007) B B Yao et al. BRITISH JOURNAL OF PHARMACOLOGY
- The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy
- (2007) V C J Wallace et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
- (2007) E J Rahn et al. BRITISH JOURNAL OF PHARMACOLOGY
- Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy
- (2007) Sanjeet Narang et al. JOURNAL OF PAIN
- AM404, an anandamide transport inhibitor, reduces plasma extravasation in a model of neuropathic pain in rat: Role for cannabinoid receptors
- (2007) G. La Rana et al. NEUROPHARMACOLOGY
- Actions of N-arachidonyl-glycine in a rat neuropathic pain model
- (2007) Leeza A.Q. Vuong et al. NEUROPHARMACOLOGY
- Analysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis
- (2007) Jessica L. Lynch et al. PAIN
- Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
- (2006) Leon Chang et al. BRITISH JOURNAL OF PHARMACOLOGY
- AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain
- (2006) Barbara Costa et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now